Proposed pharmaceutical tariffs increase costs for public health care, potentially reducing generic medicines availability.
Pharmaceutical tariffs proposed by the Trump administration would increase costs for public health care payers and potentially reduce the availability of important generic medicines in the United States.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: